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Families with multiple male children with intellectual disability (ID) are usually suspected 
of having disease due to a X-linked mode of inheritance and genetic studies focus on 
analysis of segregating variants in X-linked genes. However, the genetic cause of ID 
remains elusive in approximately 50% of affected individuals. Here, we report the analysis 
of next-generation sequencing data in 274 affected individuals from 135 families with a 
family history suggestive of X-linked ID. Genetic diagnoses were obtained for 19% (25/135) 
of the families, and 24% (33/135) had a variant of uncertain significance. In 12% of cases 
(16/135), the variants were not shared within the family, suggesting genetic heterogeneity 
and phenocopies are frequent. Of all the families with reportable variants (43%, 58/135), 
we observed that 55% (32/58) were in X-linked genes, but 38% (22/58) were in autosomal 
genes, while the remaining 7% (4/58) had multiple variants in genes with different modes 
on inheritance. This study highlights that in families with multiple affected males, X linkage 
should not be assumed, and both individuals should be considered, as different genetic 
etiologies are common in apparent familial cases.
Keywords: intellectual disability, Mendelian disease, next-generation sequencing, autosomal dominant, X-linked, 
mosaicism
INTRODUCTION
Mendelian types of intellectual disability (ID) were first identified by documenting familial 
forms of the disease that had an X-linked mode of inheritance. These families were clinically 
recognized by an excess of affected males linked in a pedigree through mothers who were 
either mildly affected or unaffected. Initially, the excess of males with ID observed in the 
population was estimated to be  due to a 10% contribution of X-linked disease genes to overall 
ID (Lehrke, 1972; Chelly and Mandel, 2001). Screening for single genes in affected individuals 
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demonstrated that this was an overestimate (Mandel and Chelly, 
2004; Raymond and Tarpey, 2006), and large-scale sequence 
analysis of the X chromosome in families demonstrated that 
X-linked variants do not always segregate in families thought 
previously to have X-linked disease (Raymond and Tarpey, 2006; 
Tarpey et  al., 2009).
With the availability of next-generation sequence (NGS) 
analysis, the systematic identification of de novo mutagenesis 
through trio analysis, and the increasing recognition of autosomal 
recessive causes of neurodevelopmental disease, the opportunity 
arises to re-evaluate the mechanisms of disease in families 
with affected individuals ascertained with the clinical assumption 
of X-linked disease. To this end, we  aimed to assess the 
contribution of genetic variation to disease in 274 individuals 
from 135 non-consanguineous families with suspected X-linked 
mode of inheritance. We studied families with multiple affected 
individuals with unexplained, moderate to severe non-syndromic 
ID using multiple NGS technologies.
MATERIALS AND METHODS
Cohort
The criteria for selecting families for sequence analysis were 
the presence of at least two affected individuals in the family 
and no known genetic cause of disease previously identified 
through routine testing. The cohort consisted of DNA samples 
from 274 affected individuals from 135 families with moderate 
to severe non-syndromic ID and analyzed within the UK10K 
Rare Diseases project (Consortium et  al., 2015) and/or the 
NIHR BioResource project (Ouwehand, 2019). Within the 
research ethical framework (IRAS 03/0/014 and 13/EE/0325), 
participants, parents, guardians, or consultee provided written 
informed consent to participate in the study.
The gender ratio was 92% (252/274) male and 8% (22/274) 
female. The majority of the families were formed by two 
affected male individuals, and in four families, there were 
three affected individuals. The predominant relationship was 
brother-brother (66%, 89/135), but also maternal uncle-nephew 
(7%, 10/135), half-brothers (5%, 7/135), and first cousins (4%, 
6/135), accounting for 83% (112/135) of the sample set. A 
smaller proportion was male-female including maternal 
grandmother-grandson, brother-sister, mother-son, and half-
brother-half-sister (Figure 1A).
Next-Generation Sequencing
Participants were sequenced using three different methodologies: 
whole-exome sequencing (WES), targeted sequencing, and 
whole-genome sequencing (WGS; Figure 1B).
WES was performed for 47% (128/274) participants, and 
candidate Single Nucleotide Variants (SNVs) and small insertions 
and deletions (indels) were identified as previously described 
(Consortium et  al., 2015). Copy number variants (CNV) were 
called based on the WES data using CoNVex (Sifrim et  al., 
2016). Targeted sequencing of 565 genes associated with ID 
was performed for 12% (32/274) individuals. A full list of 
the sequenced genes and details of the experiment has been 
described elsewhere (Grozeva et  al., 2015). Additionally, 29% 
(80/274) individuals were sequenced by both WES and 
targeted sequencing.
WGS analysis was performed for 12% (34/274) of the 
participants within the NIHR BioResource project, and SNVs/
indels and structural variants were identified as previously 
described (Carss et al., 2017; Sanchis-Juan et al., 2018). Genome 
build GRCh37/hg19 was used for mapping and variant calling. 
Sequencing data have been deposited in EGA (accession numbers 
in Data Availability Statement) and all pathogenic variants in 
Supplementary Table S1 have been submitted to ClinVar (with 
accession numbers from SCV000897731 to SCV000897758).
Variant Interpretation
Analysis of the variants obtained through the three different 
sequencing methodologies was largely similar. To identify 
pathogenic variants, a two-step protocol of automated variant 
filtering followed by manual review was used. In the automated 
filtering, variants were filtered by quality and frequency as 
previously described (Carss et  al., 2017). SNV/indel analysis 
was restricted to known disease-associated genes, which were 
gathered from sources including OMIM1, DDG2P (Wright 
et  al., 2015), and literature searches, then curated to ensure 
they comply with previously described criteria (Wright et  al., 
2015). The final list comprised of 1,334 genes. Subsequently, 
manual review of all the variants that passed the automated 
filtering in those genes was performed, according to the ACMG 
guidelines (Richards et al., 2015). Pathogenic, likely pathogenic 
and variants of uncertain significance (VUS) were reported 
to the recruiting clinician. All reported variants were 
independently confirmed.
RESULTS
Variant Identification
A total number of 66 variants were reported in 38% (103/274) 
of individuals (Figure 1C). Seventy-six percent (50/66) of the 
variants were novel (not previously reported in HGMD Pro 
or ClinVar; Supplementary Table S1). Forty SNVs, 18 indels, 
and 8 CNVs provided 61, 27, and 12% of the reported variants, 
respectively. The CNVs were at known loci, previously reported 
to be associated with developmental delay, ID, or schizophrenia 
(Figure 1D). Coverage distribution for the eight CNVs and 
IGV plots for all the reported indels are available in 
Supplementary Figures S1, S2, respectively.
Reportable SNVs/indels were identified in 47 genes. The 
most frequent genes were ATRX and SLC2A1, with variants 
identified in four and three families, respectively, while other 
genes were only seen in a single family. This is consistent 
with the observed genetic heterogeneity of ID and the low 
contribution of variation at individual loci to the total prevalence 
(Carvill and Mefford, 2015; Grozeva et  al., 2015).
1 http://www.omim.org/
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Correspondence Between Whole-Exome 
Sequencing and Targeted Sequencing Data
A total number of 80 individuals were sequenced with both 
WES and targeted sequencing platforms. Of these, 32 reportable 
variants were observed in 31 individuals. The correspondence 
between both platforms was assessed for SNVs/indels in genes 
included in the targeted sequencing gene panel, accounting 
for 19 variants.
The correspondence rate was 74% (14/19). Five variants 
were identified by WES but not targeted sequencing analysis. 
IGV plots for the alignments of these variants are in 
Supplementary Figure S3. Two of them were indels 
[NM_139058.2(ARX):c.1445_1448  +  1dup and NM_130839.2
(UBE3A):c.983_987del] in a low coverage or poor quality region, 
supporting the view that there are still errors associated with 
indel calling from targeted sequencing compared to WES.
For the other three discordant variants, two were in regions 
with no read coverage in the targeted sequencing data 
[NM_000033.3(ABCD1):c.854G > A and NM_005629.3(SLC6A8)
:c.1693dup], and one had a read depth of one 
[NM_001493.2(GDI1):c.359C > T], therefore precluding variant 
detection. It has to be noted the presence of highly homologous 
pseudogenes and high GC content of SLC6A8 genomic sequence 
that complicates the analysis of variants in this region (Yu 
et  al., 2013) and could explain why the variant was missing 
from the targeted sequencing data.
As no individuals were sequenced by both WES and WGS, 
direct comparison of these technologies was not possible within 
this study. Furthermore, as only 34 samples received analysis by 
WGS in this study, in-depth analysis of coverage and yield from 
WGS compared to WES is not reported here (Carss et al., 2017).
Diagnostic Yield in Families With a  
Family History Suggestive of X-Linked 
Intellectual Disability
Reportable variants were observed in 43% of the families 
(58/135): 19% (25/135) were pathogenic or likely pathogenic 
and 24% (33/135) were VUS. For families with multiple reportable 
A B
C D
FIGURE 1 | (A) Relationships within the studied families. (B) Number of individuals sequenced with each NGS technology by pathogenicity of the variant. (C) Total 
number of variants by mode of inheritance and pathogenicity scores (including SNVs/indels and CNVs). (D) Number of unique per family reported variants by type 
and consequence. WES, whole-exome sequencing; TS, targeted sequencing; WGS, whole-genome sequencing; AD, autosomal dominant; AR, autosomal 
recessive; XLR, X-linked recessive.
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variants presenting different pathogenicity assessments, the most 
deleterious one was considered. The reported variants were 
shared by individuals from the same family for the majority 
of cases (72%, 42/58). However, there were differences in 28% 
(16/58) of the families. More specifically, 13 had variants 
reported only for one individual, while in the remaining three 
families, both affected individuals had different reported variants 
(including one case where there was a shared and a unique 
variant only present in one individual; Figure 2A). The number 
of pathogenic variants by mode of inheritance of the gene is 
presented in Figure 2B.
In the 58 families with reportable variants, 55% (32/58) had 
variants in X-linked recessive genes, 38% (22/58) had variants 
in autosomal genes, and three additional families (5%) had 
multiple reportable variants presenting different modes of 
inheritance (Supplementary Table S2). Interestingly, these 
proportions also varied depending on the family structure. 
Brother-brother and maternal uncle-nephew relationships had 
a higher proportion of variants in X-linked genes [57 (21/37) 
and 86% (6/7), respectively] compared to variants in autosomal 
genes [41 (15/37) and 0% (0/37)]. However, for brother-sister 
pairs, the number of families with reported variants in autosomal 
genes (63%, 5/8) was higher than in X-linked genes (25%, 2/8).
Additionally, we  note that in the brother-brother pairs, the 
proportion of variants in autosomal genes was higher for 
dominant (80%, 12/15) than recessive (20%, 3/15) modes of 
inheritance (Supplementary Figure S4). This was different in 
other relationships such as brother-sister, where only 20% (1/5) 
of the families had variants in autosomal dominant genes.
Identification of Families With Variants in 
Autosomal Genes
As previously mentioned, 58 families had at least one reportable 
variant. As expected, a large number of these were in X-linked 
recessive genes (55%, 32/58; Figure 2B). Of those, the majority 
were novel, including a loss-of-function (LOF) variant in 
HNRNPH2 gene, which was hemizygous in a maternal uncle 
and nephew (Family F133) that presented with severe ID, 
epilepsy, autism, developmental delay, and dysmorphic features. 
Pathogenic variants in this gene previously have only been 
reported in females, and so this case is the first report in the 
literature of a hemizygous LOF variant in HNRNPH2 in males 
(additional information in Supplementary Data, Section 1.1).
Interestingly, a considerable proportion of families had 
reportable variants in autosomal genes (38%, 22/58), of which 
seven were in recessive genes, 15 were in dominant genes. 
Additionally, 7% of the families (4/58) presented with multiple 
variants with different modes of inheritance (Figure 2B). Three 
examples of families with variants in autosomal genes are 
presented below:
A
B
FIGURE 2 | (A) Outline of the number of reported variants identified in the studied cohort. Families with reportable variants are separated in three categories:  
(1) number of families where affected members have the same variant (same); (2) number of families where only one family member has a variant (one); and (3) 
number of families where both affected individuals had different variants (different). (B) Number of families are showed by mode of inheritance of the variant/s. AD, 
autosomal dominant; AR, autosomal recessive; XLR, X-linked recessive.
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In family F002, we identified a frameshift variant in TCF20 
(chr22:42607507 GTC  >  G; NM_005650.2:c.3803_3804del; 
NP_005641.1: p.Arg168Thrfs*9), shared by two male siblings 
with severe ID (Torti et  al., 2019). De novo and inherited 
pathogenic variants in TCF20 have been recently linked to 
developing ID, dysmorphic features, hypotonia, and neurological 
impairments (Vetrini et al., 2019). Further investigations showed 
that another affected male sibling carried the same variant 
that was not observed in the mother and two unaffected 
male siblings by Sanger sequence analysis. The father was 
unavailable for segregation analysis. The parents were reported 
as phenotypically unaffected. Additional information with 
respect to this family and the variant is provided in 
Supplementary Data, Section 1.2.
In family F107, we  identified a splice site variant in SATB2 
(chr2:200233432  T  >  C; NM_015265.3: c.598-2A  >  G) present 
in two male siblings (Bengani et  al., 2017). Sanger sequencing 
analysis of peripheral blood-derived DNA from both parents 
revealed a normal sequence at this base. While most of the 
variants reported in SATB2 are de novo, the observation that 
both siblings in this family shared the same LOF variant 
suggests that one of the parents was either gonadal mosaic 
or had too low level of somatic mosaicism to be  detected by 
Sanger sequence analysis. Additional information is provided 
in Supplementary Data, Section 1.3.
In family F004, a shared 5  bp deletion frameshift variant 
was identified in UBE3A (chr15:25616333 CATTGT>C; 
NM_130839.2:c.983_987del; NP_570854.1: p.Tyr328Cysfs*18) 
in two affected male siblings. The children presented with 
global developmental delay with absent or minimal speech 
and significantly delayed age of walking. The two siblings 
had been previously tested for Angelman syndrome using 
microarray and methylation assays, which were both negative. 
As UBE3A is an imprinted gene, there could be  four possible 
origins of the variant in the boys: (1) maternal germline 
mosaicism; (2) low level somatic mosaicism in the mother; 
(3) a paternally inherited variant in the mother; or (4) a 
de novo variant in the mother on the paternally inherited 
allele. The mother of the siblings was not available for further 
testing; therefore, the origin of this variant in the two boys 
could not be determined. Additional information is provided 
in the Supplementary Data, Section 1.4.
DISCUSSION
The aim of this study was to assess the contribution of genetic 
variation to disease in families affected with moderate to 
severe non-syndromic ID, with suspected X-linked inheritance 
due to family history. The overall diagnostic yield was 19% 
(25/135), and 24% (33/135) of the studied families had a 
VUS, comparable to those previously reported in similar studies 
(Tzschach et al., 2015; Hu et al., 2016). However, 57% (77/135) 
of the studied cohort remained unresolved. This could 
be because some of the studied individuals may have undetected 
pathogenic variants in coding exonic regions of low pull-down 
efficiency due to using targeted sequencing or WES. 
Others may harbor variants that were not called using the 
current algorithms that were filtered out during quality control 
filtering or were in genes that were absent from our curated 
gene list. Non-coding regions or complex rearrangements were 
also missed (Sanchis-Juan et  al., 2018) in the families only 
tested using WES and/or targeted sequencing and oligogenic 
or multigenic modes of inheritance were not considered in 
any individuals (Niemi et  al., 2018).
The studied cohort was ascertained due to the presence of 
moderate to severe non-syndromic ID and was relatively biased 
against recruitment of families with a clearly syndromic form 
of disease. Despite this, rare variants were observed in genes 
normally associated with distinct syndromic phenotypes [such 
as MECP2 (MIM: 300673), SPG7 (MIM: 607259), MED12 
(MIM: 305450), and CASK (MIM: 300749)] suggesting broader 
contribution of these genes to ID. Previous studies have also 
observed similar phenotypic variability in individuals with 
mutations in known syndromic ID-associated genes (Guerrini 
et  al., 2000; Field et  al., 2006; Hoyer et  al., 2012; Rauch et  al., 
2012; Santen et  al., 2013; Grozeva et  al., 2015). Therefore, 
studying NGS data in large sample sets of patients with ID 
will help to provide information about the full spectrum of 
the associated phenotype presentation of mutations in a 
particular gene.
As expected, in families with reported variants, the majority 
of variants were shared in the affected individuals, but in 
28% (16/58) of families, the variants were discordant. As ID 
is a heterogeneous disorder associated with many highly 
penetrant genes, the evidence of multiple different genetic 
etiologies within a family is perhaps unsurprising. In view 
of this, we  recommend cautious use and interpretation of 
the ACMG guidelines, specifically BS4 category that is a 
strong predictor against pathogenicity when variants do not 
segregate with disease.
Furthermore, in 55% (32/58) of families with reported 
variants, these were identified, as expected, in genes on the 
X chromosome. Nevertheless, 38% of the families (22/58) 
presented variants in autosomal genes. Of these, only seven 
families had variants in autosomal recessive genes, consistent 
with previous results that have shown that ID is infrequently 
recessive in an outbred population (Grozeva et  al., 2015; 
Martin et  al., 2018).
Interestingly, 15 families had variants in autosomal genes 
that were shared by both members of the family, nine were 
in genes with a dominant mode of inheritance (4/9 
were pathogenic and 5/9 were VUS; Figure 2B). In eight 
families, this occurred in brother-brother pairs, and in 
one family, this was observed in a mother-son pair 
(Supplementary Figure S4). Three of nine families are further 
described in Supplementary Data (Sections 1.2–1.4). No 
second pathogenic event was identified in any individual that 
had WES or WGS performed from these nine families, and 
in those that had targeted sequencing only, variants identified 
were likely or clearly pathogenic SNVs. Possible explanations 
for the observed familial variants in autosomal genes shared 
by the pairs are reduced penetrance of the variant in a parent, 
parent of origin effects for imprinted genes, germ line 
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mosaicism in a parent, and low level somatic mosaicism 
in a parent that was undetectable. Mosaicism has been 
increasingly recognized as mutational mechanism in disease, 
with studies suggesting it may explain as much as 3.8–28.5% 
of apparently de novo variants (Biesecker and Spinner, 2013; 
Xu et  al., 2015; Rahbari et  al., 2016; Zillhardt et  al., 2016; 
Jonsson et  al., 2018).
This study uses NGS approaches in families affected with 
undiagnosed, moderate to severe, non-syndromic ID with a 
family history consistent with X-linked mode of inheritance. 
We  show that, although X-linked inheritance is frequent in 
families with more than one affected individual, non-shared 
variants and autosomal inheritance are a significant cause of 
disease. Our results highlight the need to delineate X-linked 
disorders from other types of inheritance in order to clinically 
manage the condition in the family and to provide more 
accurate recurrence risk estimates. We  therefore recommend 
more extensive genomic testing of families with potential 
X-linked mode of inheritance.
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SUPPLEMENTARY TABLE S1 | List of participants and variants identified.
SUPPLEMENTARY TABLE S2 |  Number and proportion of families with 
reportable variants by mode of inheritance. XLR = X-linked recessive; 
auto = autosomal.
SUPPLEMENTARY FIGURE S1  |  Eight reported copy number variants (CNVs) 
identified by whole-exome sequencing (WES). Plots show changes in coverage of 
short-read WES across the entire chromosome (normalized depth t score using 
CNView, n=250) (Collins, 2016). Deletions and duplications are colored in red and 
blue respectively. SegDup=sites of multiallelic segmental duplications. All family 
relationships with reported CNVs are brother-brother, except from F130 (half-
brothers) and F113 (mother-son). (A) Deletion in F007 identified in both affected 
individuals. (B) Duplication in F019 identified only in one affected individual. (C) 
Deletion in F031 identified only in one affected individual. (D) Duplication in F113 
identified in both mother (mildly affected) and affected son. (E) Duplication in 
F115 identified at the nearly end of chromosome X in both affected individuals. 
(F) Deletion in F126 identified in both affected individuals. (G) Deletion in F129 
identified in both affected individuals. (H) Deletion in F130 identified in one 
affected individual.
SUPPLEMENTARY FIGURE S2  |  Reportable insertions/deletions identified in 
this study. Plots were obtained using IGV for the families (A) F001, (B) F002, (C), 
F004, (D) F005, (E) F006, (F) F009, (G) F011, (H) F012, (I) F013, (J) F025, (K) 
F093, (L) F108, (M) F110, (N) F114, (O) F118, (P) F125, (Q) F127, (R) F128.
Additional details of the variants are present in Supplemental Table 1.
SUPPLEMENTARY FIGURE S3  |  Correspondence between WES and 
targeted sequencing data. IGV plots for the variants identified by WES (bottom) 
but absent from the targeted sequencing data (top) in the individuals (A) F001-A, 
(B) F004-A, (C) F114-A, (D) F109-B and (E) F112-A.
SUPPLEMENTARY FIGURE S4  |  (A) Number of families with reported 
variants identified in the studied cohort by mode of inheritance. If multiple genes 
with different mode of inheritance are identified in a family, the most deleterious 
pathogenicity is considered. (B) Number of families are grouped if the variants 
are: shared by all the family members (Same), only present in one individual (One) 
or multiple family members have different reportable variants (Different). Shading 
represents the mode of inheritance of the variant/s. AD=autosomal dominant; 
AR=autosomal recessive; XLR=X-linked recessive.
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